Trial intelligence / Profile preview

IDEA-070 for PDT-induced pain and inflammation in actinic keratosis

NCT00269074Phase 2Completed

Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in actinic keratosis (AK) comparing IDEA-070 with Placebo (2 arms). Primary endpoints: Pain induced by PDT and Inflammation induced by PDT. Started Jan 2006; status: completed.

02

Drugs

diractin
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT00269074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00269074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call